Delhi High Court allows Natco to make Roche's spinal muscular atrophy drug in public interest

The Delhi High Court granted Natco Pharma permission to manufacture Roche's spinal muscular atrophy drug, considering it in the public interest. The court weighed the need for affordable access to a life-saving drug against patent rights. It emphasized the importance of balancing innovation with public health needs. The ruling aims to make the drug more accessible to patients in India. The court highlighted the necessity of ensuring that essential medicines are available at reasonable costs.